- Sarepta Therapeutics (NASDAQ:SRPT) commences a $500M public offering of common stock. Price, volume and terms have yet to be announced.
- Net proceeds will fund clinical trials, commercialization activities, business development activities, manufacturing and potential licensing or acquisition deals.
- Shares are off 4% after hours.
Sarepta launches $500M stock offering; shares down 4% after hours
Recommended For You
About SRPT Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| SRPT | - | - |
| Sarepta Therapeutics, Inc. | ||